The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Open accessAbstract
Angiopoietins 1–4 (Ang1–4) represent an important family of growth factors, whose activities are mediated through the tyrosine kinase receptors, Tie1 and Tie2. The best characterized are angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2). Ang1 is a potent angiogenic growth factor signaling through Tie2, whereas Ang2 was initially identified as a vascular disruptive agent with antagonistic activity through the same receptor. Recent data demonstrates that Ang2 has context-dependent agonist activities. Ang2 plays important roles in physiological processes and the deregulation of its expression is characteristic of several diseases. In this review, we summarize the activity of Ang2 on blood and lymphatic endothelial cells, its significance in human physiology and disease, and provide a current view of the molecular signaling pathways regulated by Ang2 in endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,923
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Acute respiratory distress syndrome
Matthay, M. A., Zemans, R. L., Zimmerman, G. A., Arabi, Y. M., Beitler, J. R., Mercat, A., Herridge, M., Randolph, A. G., & Calfee, C. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0069-0 · Cited by 2,387
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706
The Structure and Function of the Endothelial Glycocalyx Layer
Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151959 · Cited by 1,198
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Yeboah, J., Folsom, A. R., Burke, G. L., Johnson, C., Polak, J. F., Post, W., Lima, J. A., Crouse, J. R., & Herrington, D. M. (2009) · Circulation · doi:10.1161/circulationaha.109.864801 · Cited by 888
Schmidt, E. P., Yang, Y., Janssen, W. J., Gandjeva, A., Perez, M. J., Barthel, L., Zemans, R. L., Bowman, J. C., Koyanagi, D. E., Yunt, Z. X., et al. (2012) · Nature Medicine · doi:10.1038/nm.2843 · Cited by 848
Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Lobov, I. B., Brooks, P. C., & Lang, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172161899 · Cited by 676 · cited 1×
“In the absence of VEGF, however, Ang2 led to vessel regression and endothelial cell death [42].”
BackgroundMazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639
Musher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Kelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A., & Semenza, G. L. (2003) · Circulation Research · doi:10.1161/01.res.0000102937.50486.1b · Cited by 611
Benjamin, E. J., Larson, M. G., Keyes, M. J., Mitchell, G. F., Vasan, R. S., Keaney, J. F., Lehman, B. T., Fan, S., Osypiuk, E., & Vita, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000112565.60887.1e · Cited by 607
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization
Potente, M., Urbich, C., Sasaki, K.-I., Hofmann, W. K., Heeschen, C., Aicher, A., Kollipara, R., DePinho, R. A., Zeiher, A. M., & Dimmeler, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23126 · Cited by 531
Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans
Parikh, S. M., Mammoto, T., Schultz, A., Yuan, H.-T., Christiani, D., Karumanchi, S. A., & Sukhatme, V. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030046 · Cited by 527
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Felcht, M., Luck, R., Schering, A., Seidel, P., Srivastava, K., Hu, J., Bartol, A., Kienast, Y., Vettel, C., Loos, E. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58832 · Cited by 479
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Wang, H.-W., Trotter, M. W. B., Lagos, D., Bourboulia, D., Henderson, S., Mäkinen, T., Elliman, S., Flanagan, A. M., Alitalo, K., & Boshoff, C. (2004) · Nature Genetics · doi:10.1038/ng1384 · Cited by 460
Scharpfenecker, M., Fiedler, U., Reiss, Y., & Augustin, H. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.01653 · Cited by 382
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Yuan, H. T., Khankin, E. V., Karumanchi, S. A., & Parikh, S. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01472-08 · Cited by 373
Partanen, J., Armstrong, E., Mäkelä, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K., & Alitalo, K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1698 · Cited by 373
(2010) · Essential Facts in Geriatric Medicine · doi:10.1201/9781785231025-47 · Cited by 333
Role of glycocalyx in leukocyte-endothelial cell adhesion
Mulivor, A. W., & Lipowsky, H. H. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00117.2002 · Cited by 328
Daly, C., Wong, V., Burova, E., Wei, Y., Zabski, S., Griffiths, J., Lai, K.-M., Lin, H. C., Ioffe, E., Yancopoulos, G. D., et al. (2004) · Genes & Development · doi:10.1101/gad.1189704 · Cited by 327
Kim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Monk, B. J., Poveda, A., Vergote, I., Raspagliesi, F., Fujiwara, K., Bae, D.-S., Oaknin, A., Ray-Coquard, I., Provencher, D. M., Karlan, B. Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70244-x · Cited by 304
Teichert-Kuliszewska, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00231-5 · Cited by 291
Endothelial destabilization by angiopoietin-2 via integrin β1 activation
Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P. (2015) · Nature Communications · doi:10.1038/ncomms6962 · Cited by 287 · cited 2×
“Moreover, β1 integrin binding and activation was Ang2-specific, but not Ang1, and expression of a membrane-bound Tie2 lacking the kinase activity blocked the activation of the integrins by Ang2 [124].”
BackgroundTie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283
Sepsis and Major Abdominal Surgery Lead to Flaking of the Endothelial Glycocalix
Steppan, J., Hofer, S., Funke, B., Brenner, T., Henrich, M., Martin, E., Weitz, J., Hofmann, U., & Weigand, M. A. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2009.04.034 · Cited by 283
Direct Cell Adhesion to the Angiopoietins Mediated by Integrins
Carlson, T. R., Feng, Y., Maisonpierre, P. C., Mrksich, M., & Morla, A. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100282200 · Cited by 268
The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
Thurston, G., & Daly, C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006650 · Cited by 266
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Daly, C., Pasnikowski, E., Burova, E., Wong, V., Aldrich, T. H., Griffiths, J., Ioffe, E., Daly, T. J., Fandl, J. P., Papadopoulos, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607538103 · Cited by 251
Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation
Scholz, A., Plate, K. H., & Reiss, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12726 · Cited by 248
Pfister, F., Feng, Y., vom Hagen, F., Hoffmann, S., Molema, G., Hillebrands, J.-L., Shani, M., Deutsch, U., & Hammes, H.-P. (2008) · Diabetes · doi:10.2337/db08-0325 · Cited by 244
Targeting pericytes for therapeutic approaches to neurological disorders
Cheng, J., Korte, N., Nortley, R., Sethi, H., Tang, Y., & Attwell, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1893-0 · Cited by 244
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Kim, M., Allen, B., Korhonen, E. A., Nitschké, M., Yang, H. W., Baluk, P., Saharinen, P., Alitalo, K., Daly, C., Thurston, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84871 · Cited by 243
Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage
Roviezzo, F., Tsigkos, S., Kotanidou, A., Bucci, M., Brancaleone, V., Cirino, G., & Papapetropoulos, A. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086553 · Cited by 221
Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., Boden-Albala, B., Sacco, R., & Homma, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.005 · Cited by 219
Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis
Holopainen, T., Saharinen, P., D’Amico, G., Lampinen, A., Eklund, L., Sormunen, R., Anisimov, A., Zarkada, G., Lohela, M., Heloterä, H., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs009 · Cited by 216
Iwama, A., Hamaguchi, I., Hashiyama, M., Murayama, Y., Yasunaga, K., & Suda, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2045 · Cited by 216
Angiopoietin-2 is increased in severe sepsis: Correlation with inflammatory mediators
Orfanos, S. E., Kotanidou, A., Glynos, C., Athanasiou, C., Tsigkos, S., Dimopoulou, I., Sotiropoulou, C., Zakynthinos, S., Armaganidis, A., Papapetropoulos, A., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000251640.77679.d7 · Cited by 213
Findley, C. M., Cudmore, M. J., Ahmed, A., & Kontos, C. D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150482 · Cited by 205
Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival
Sfiligoi, C., de Luca, A., Cascone, I., Sorbello, V., Fuso, L., Ponzone, R., Biglia, N., Audero, E., Arisio, R., Bussolino, F., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10851 · Cited by 203
Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
Gerald, D., Chintharlapalli, S., Augustin, H. G., & Benjamin, L. E. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4697 · Cited by 202
Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice
Dellinger, M., Hunter, R., Bernas, M., Gale, N., Yancopoulos, G., Erickson, R., & Witte, M. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.04.024 · Cited by 190
Lee, K. W., Lip, G. Y. H., & Blann, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000138112.90641.7f · Cited by 189
Dunk, C., Shams, M., Nijjar, S., Rhaman, M., Qiu, Y., Bussolati, B., & Ahmed, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65089-4 · Cited by 187
Biological characterization of angiopoietin‐3 and angiopoietin‐4
Lee, H. J., Cho, C.-H., Hwang, S.-J., Choi, H.-H., Kim, K.-T., Ahn, S. Y., Kim, J.-H., Oh, J.-L., Lee, G. M., & Koh, G. Y. (2004) · The FASEB Journal · doi:10.1096/fj.03-1466com · Cited by 177
Angiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 171
Chong, A. Y., Caine, G. J., Freestone, B., Blann, A. D., & Lip, G. Y. H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.042 · Cited by 169
Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
Keskin, D., Kim, J., Cooke, V. G., Wu, C.-C., Sugimoto, H., Gu, C., De Palma, M., Kalluri, R., & LeBleu, V. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.035 · Cited by 165
The Angiopoietin/Tie-2 System Regulates Pericyte Survival and Recruitment in Diabetic Retinopathy
Cai, J., Kehoe, O., Smith, G. M., Hykin, P., & Boulton, M. E. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1206 · Cited by 164
Brown, L. F., Dezube, B. J., Tognazzi, K., Dvorak, H. F., & Yancopoulos, G. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65088-2 · Cited by 163
Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions
Sajib, S., Zahra, F. T., Lionakis, M. S., German, N. A., & Mikelis, C. M. (2018) · Angiogenesis · doi:10.1007/s10456-017-9583-4 · Cited by 160
Self-citationMochizuki, Y., Nakamura, T., Kanetake, H., & Kanda, S. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.1.175 · Cited by 152
Endothelial glycocalyx breakdown is mediated by angiopoietin-2
Lukasz, A. H., Hillgruber, C., Oberleithner, H., Kusche‐Vihrog, K., Pavenstädt, H., Rovas, A., Hesse, B., Goerge, T., & Kümpers, P. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx023 · Cited by 152
Differential regulation of blood vessel formation between standard and delayed bone healing
Lienau, J., Schmidt‐Bleek, K., Peters, A., Haschke, F., Duda, G. N., Perka, C., Bail, H. J., Schütze, N., Jakob, F. J., & Schell, H. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20870 · Cited by 151
Kümpers, P., Gueler, F., David, S., Slyke, P. V., Dumont, D., Park, J.-K., Bockmeyer, C. L., Parikh, S. M., Pavenstädt, H. J., Haller, H. G., et al. (2011) · Critical Care · doi:10.1186/cc10523 · Cited by 151
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Carota, I. A., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 148
Huang, Y.-Q., Li, J., Hu, L., Lee, M., & Karpatkin, S. (2002) · Blood · doi:10.1182/blood.v99.5.1646 · Cited by 143
Angiopoietin-2: Development of inhibitors for cancer therapy
Hu, B., & Cheng, S.-Y. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0017-3 · Cited by 136
Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions
Zheng, W., Nurmi, H., Appak, S., Sabine, A., Bovay, E., Korhonen, E. A., Orsenigo, F., Lohela, M., D’Amico, G., Holopainen, T., et al. (2014) · Genes & Development · doi:10.1101/gad.237677.114 · Cited by 134
Reilly, J. P., Wang, F., Jones, T. K., Palakshappa, J. A., Anderson, B. J., Shashaty, M. G. S., Dunn, T. G., Johansson, E. D., Riley, T. R., Lim, B., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5328-0 · Cited by 130
Hansen, T. M., Singh, H., Tahir, T. A., & Brindle, N. P. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.007 · Cited by 126
Zhang, E. G., Smith, S. K., Baker, P. N., & Charnock-Jones, D. S. (2001) · Molecular Medicine · doi:10.1007/bf03401869 · Cited by 125
Liu, X., Chopp, M., Zhang, R. L., Hozeska‐Solgot, A., Gregg, S. R., Buller, B., Lü, M., & Zhang, Z. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006551 · Cited by 109
Davis, J. S., Yeo, T. W., Piera, K. A., Woodberry, T., Celermajer, D. S., Stephens, D. P., & Anstey, N. M. (2010) · Critical Care · doi:10.1186/cc9020 · Cited by 108
Targeting pericytes for neurovascular regeneration
Geranmayeh, M. H., Rahbarghazi, R., & Farhoudi, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0340-8 · Cited by 108
Thomas, M., Felcht, M., Kruse, K., Kretschmer, S., Deppermann, C., Biesdorf, A., Rohr, K., Benest, A. V., Fiedler, U., & Augustin, H. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.097543 · Cited by 101
Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality
David, S., Ghosh, C. C., Kümpers, P., Shushakova, N., Van Slyke, P., Khankin, E. V., Karumanchi, S. A., Dumont, D., & Parikh, S. M. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2010 · Cited by 96
Targeting β1-integrin inhibits vascular leakage in endotoxemia
Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722317115 · Cited by 95
Yoshiji, H., Kuriyama, S., Noguchi, R., Yoshii, J., Ikenaka, Y., Yanase, K., Namisaki, T., Kitade, M., Uemura, M., Masaki, T., et al. (2005) · Gut · doi:10.1136/gut.2005.067900 · Cited by 94
Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS
Hendrickson, C. M., & Matthay, M. A. (2018) · Pulmonary Circulation · doi:10.1177/2045894018769876 · Cited by 94
Angiopoietin 2 induces astrocyte apoptosis via αvβ5-integrin signaling in diabetic retinopathy
Yun, J.-H., Park, S. W., Kim, J. H., Park, Y., Cho, C.-H., & Kim, J. H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.347 · Cited by 87
Kümpers, P., David, S., Haubitz, M., Hellpap, J., Horn, R., Bröcker, V., Schiffer, M., Haller, H. G., & Witte, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094664 · Cited by 85
Marth, C., Vergote, I., Scambia, G., Oberaigner, W., Clamp, A., Berger, R., Kurzeder, C., Colombo, N., Vuylsteke, P., Lorusso, D., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.004 · Cited by 79
Angiopoietin 2 and Cardiovascular Disease in Dialysis and Kidney Transplantation
David, S., Kümpers, P., Hellpap, J., Horn, R., Leitolf, H., Haller, H. G., & Kielstein, J. T. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.030 · Cited by 79
Papadopoulos, K. P., Kelley, R. K., Tolcher, A. W., Razak, A. R. A., Loon, K. V., Patnaik, A., Bedard, P. L., Alfaro, A. A., Beeram, M., Adriaens, L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1221 · Cited by 79
Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesis
An, Y., Sun, K., Joffin, N., Zhang, F., Deng, Y., Donzé, O., Kusminski, C. M., & Scherer, P. E. (2017) · eLife · doi:10.7554/elife.24071 · Cited by 79
Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia
Gutbier, B., Neuhauß, A., Reppe, K., Ehrler, C., Santel, A., Kaufmann, J., Scholz, M. R., Weißmann, N., Morawietz, L., Mitchell, T. J., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1733oc · Cited by 77
Saber, T., Veale, D. J., Balogh, E., McCormick, J., NicAnUltaigh, S., Connolly, M., & Fearon, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023540 · Cited by 76
Stiehl, T., Thamm, K., Kaufmann, J., Schaeper, U., Kirsch, T., Haller, H. G., Santel, A., Ghosh, C. C., Parikh, S. M., & David, S. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000524 · Cited by 75
Angiopoietin‐2 levels as a biomarker of cardiovascular risk in patients with hypertension
Patel, J. V., Lim, H. S., Varughese, G. I., Hughes, E. A., & Lip, G. Y. H. (2008) · Annals of Medicine · doi:10.1080/07853890701779586 · Cited by 73
Angiopoietin-2-Driven Vascular Remodeling in Airway Inflammation
Tabruyn, S. P., Colton, K., Morisada, T., Fuxe, J., Wiegand, S. J., Thurston, G., Coyle, A. J., Connor, J. R., & McDonald, D. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100059 · Cited by 71
Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases
Singh, H., Milner, C. S., Aguilar-Hernández, M., Patel, N. R., & Brindle, N. P. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.04.002 · Cited by 65
Acceleration of Diabetic Wound Healing by an Angiopoietin Peptide Mimetic
Slyke, P. V., Alami, J., Martin, D., Kuliszewski, M. A., Leong-Poi, H. M., Sefton, M. V., & Dumont, D. J. (2008) · Tissue Engineering Part A · doi:10.1089/ten.tea.2007.0400 · Cited by 60
Zhao, Q., Hu, J., Xiang, J., Gu, Y., Jin, P., Hua, F., Zhang, Z., Liu, Y., Zan, K., Zhang, Z., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.003 · Cited by 58
Kumpers, P., Hellpap, J., David, S., Horn, R., Leitolf, H., Haller, H. G., & Haubitz, M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn755 · Cited by 58
Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden
Bohn, K. A., Adkins, C. E., Nounou, M. I., & Lockman, P. R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00193 · Cited by 56
Hyman, D. M., Rizvi, N. A., Natale, R. B., Armstrong, D. K., Birrer, M. J., Recht, L. D., Dotan, E., Makker, V., Kaley, T. J., Kuruvilla, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1775 · Cited by 56
Nguyen, V. P. K. H., Chen, S. H., Trinh, J., Kim, H. L., Coomber, B. L., & Dumont, D. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-10 · Cited by 55
Role of Angiopoietins and Tie-2 in Diabetic Retinopathy
Khalaf, N. A., Helmy, H., labib, H., Fahmy, I., Hamid, M. A. E., & Moemen, L. A. (2017) · Electronic physician · doi:10.19082/5031 · Cited by 54
Trani, M., & Dejana, E. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000137 · Cited by 52
Microvascular Plasticity After Experimental Stroke: A Molecular and MRI Study
Moisan, A., Favre, I., Rome, C., Grillon, E., Naëgelé, B., Barbieux, M., de Fraipont, F., Richard, M., Barbier, E., Remy, C. C., et al. (2014) · Cerebrovascular Diseases · doi:10.1159/000368597 · Cited by 51
Rajput, C., Tauseef, M., Farazuddin, M., Yazbeck, P., Amin, M. R., Ragunathrao, V. A. B., Sharma, T., & Mehta, D. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306997 · Cited by 49
Syrjälä, S. O., Tuuminen, R., Nykänen, A. I., Raissadati, A., Dashkevich, A., Keränen, M. A. I., Arnaudova, R., Krebs, R., Leow, C. C., Saharinen, P., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12672 · Cited by 46
The Enigma of miRNA Regulation in Cancer
Pradhan, A. K., Emdad, L., Das, S. K., Sarkar, D., & Fisher, P. B. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.06.001 · Cited by 45
Trieu, M., van Meurs, M., van Leeuwen, A. L. I., Slyke, P. V., Hoang, V., Geeraedts, L. M. G., Boer, C., & van den Brom, C. E. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001907 · Cited by 45
Dekker, N., van Meurs, M., van Leeuwen, A. L. I., Hofland, H. M., Slyke, P. V., Vonk, A. B. A., Boer, C., & van den Brom, C. E. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.05.049 · Cited by 45
MicroRNA-based Targeted Therapeutics in Pancreatic Cancer
Gürbüz, N., & Özpolat, B. (2019) · Anticancer Research · doi:10.21873/anticanres.13144 · Cited by 44
Angiopoietin-2 associations with the underlying infection and sepsis severity
Lymperopoulou, K., Velissaris, D., Kotsaki, A., Antypa, E., Georgiadou, S., Τσαγανός, Θ., Koulenti, D., Paggalou, E., Damoraki, G., Karagiannidis, N., et al. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.022 · Cited by 42
MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells
Wang, H., Hang, C., Ou, X., Nie, J., Ding, Y.-T., Xue, S.-G., Gao, H., & Zhu, J. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0331-4 · Cited by 42
Yin, J., Gong, G., Sun, C., Yin, Z., Zhu, C., Wang, B., Hu, Q., Zhu, Y., & Liu, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.078 · Cited by 42
Dalton, A. C., Shlamkovich, T., Papo, N., & Barton, W. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163732 · Cited by 41
Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease
Tsai, Y., Lee, C., Chiu, Y., Kuo, H., Lee, S., Hwang, S., Kuo, M., & Chen, H. (2016) · Scientific Reports · doi:10.1038/srep39400 · Cited by 40
on behalf of the Hellenic Sepsis Study Group, Ioakeimidou, A., Pagalou, E., Kontogiorgi, M., Antoniadou, E., Kaziani, K., Psaroulis, K., Giamarellos‐Bourboulis, E. J., Prekates, A., Antonakos, N., et al. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2988-6 · Cited by 40
Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
Dong, Z., Chen, J., Yang, X., Zheng, W., Wang, L., Fang, M., Wu, M., Yao, M., & Yao, D. (2018) · Oncotarget · doi:10.18632/oncotarget.24061 · Cited by 38
Angiopoietin 2 in placentation and tumor biology: The yin and yang of vascular biology
Wang, Q., & Lash, G. E. (2017) · Placenta · doi:10.1016/j.placenta.2017.03.021 · Cited by 37
Lee, H. S., Oh, S. J., Lee, K.-H., Lee, Y.-S., Ko, E., Kim, K. E., Kim, H.-C., Kim, S., Song, P. H., Kim, Y.-I., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572594 · Cited by 36
Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells
Song, S.-H., Kim, K. L., Lee, K., & Suh, W. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.009 · Cited by 36
miRNA-dependent cross-talk between VEGF and Ang-2 in hypoxia-induced microvascular dysfunction
Zhao, R., Qian, L., & Jiang, L. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.096 · Cited by 36
Lomas‐Neira, J., Heffernan, D. S., Ayala, A., & Monaghan, S. F. (2015) · Shock · doi:10.1097/shk.0000000000000499 · Cited by 31
Korpela, E., Yohan, D., Chin, L. C. L., Kim, A., Huang, X., Sade, S., Slyke, P. V., Dumont, D., & Liu, S. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-614 · Cited by 29
Liu, X., Ma, T., Liu, W., Cai, Q., Wang, L., Song, H., Yuan, L., & Liu, Z. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.01.010 · Cited by 25
Schuldt, E., Lieb, W., Dörr, M., Lerch, M. M., Völzke, H., Nauck, M. A., & Friedrich, N. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.003 · Cited by 25
Multiple Effects of Angiopoietin-2 Blockade on Tumors
Lewis, C. E., & Ferrara, N. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.016 · Cited by 24
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis
Belloni, D., Marcatti, M., Ponzoni, M., Ciceri, F., Veschini, L., Corti, A., Cappio, F. C., Ferrarini, M., & Ferrero, E. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.10.017 · Cited by 22
Ye, F.-C., Zhou, F.-C., Nithianantham, S., Chandran, B., Yu, X.-L., Weinberg, A., & Gao, S. (2013) · Journal of Virology · doi:10.1128/jvi.03303-12 · Cited by 22
Paczkowska, E., Rogińska, D., Pius‐Sadowska, E., Jurewicz, A., Piecyk, K., Safranow, K., Dziedziejko, V., Grzegrzółka, R., Bohatyrewicz, A., & Machaliński, B. (2014) · Journal of Spinal Cord Medicine · doi:10.1179/2045772314y.0000000227 · Cited by 20
Yu, X., Sha, J., Shao, X., Qin, S., Conrad, P., Ghosh, S. K., Weinberg, A., & Ye, F. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1196303 · Cited by 20
Cervical cancer cell–derived angiopoietins promote tumor progression
Yang, P., Chen, N., Yang, D., Crane, J. L., Huang, B., Dong, R., Yi, X., Guo, J., Cai, J., & Wang, Z. (2017) · Tumor Biology · doi:10.1177/1010428317711658 · Cited by 20
Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population
Chen, Y., Wu, Y., Zhang, X., Zeng, H., Liu, Y., Wu, Q., Chen, Y., Zhu, G., Pan, Q., Jin, L., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.017 · Cited by 20
Wang, K., Kang, L., Liu, W., Song, Y., Wu, X., Zhang, Y., Hua, W., Zhao, K., Li, S., Tu, J., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3576 · Cited by 16
Angiopoietin 2 signaling plays a critical role in neural crest cell migration
McKinney, M. C., McLennan, R., & Kulesa, P. M. (2016) · BMC Biology · doi:10.1186/s12915-016-0323-9 · Cited by 12
Zhan, J., Gu, Z., & Feng, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1620 · Cited by 9
Cited by
Macrophage Polarization States in the Tumor Microenvironment
Boutilier, A. J., & Elsawa, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136995 · Cited by 1,631
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Jin, Y., Ji, W., Yang, H., Chen, S., Zhang, W., & Duan, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00454-7 · Cited by 399
Mettu, P. S., Allingham, M. J., & Cousins, S. W. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100906 · Cited by 370
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Olejarz, W., Kubiak-Tomaszewska, G., Chrzanowska, A., & Lorenc, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165840 · Cited by 299
Metadata
- Authors
- Akwii, R. G., Sajib, M. S., Zahra, F. T., & Mikelis, C. M.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-05-17
- Volume
- 8
- Issue
- 5
- Pages
- 471
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2944933026
- Cited by
- 543
- References
- 136
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.